Impact Factor
3.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.14
1,256 total citations
h5-index
42
h5 depth signal
Cited share
74.0%
236 of 319
Total citations
1,256
Citation footprint
Metric signal
3.45
External metric anchor
Self-citation
7.6%
96 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
348
United Kingdom
172
France
151
Australia
137
Switzerland
132
Citing Fields of Research
Tropical Diseases
425
Virology
411
Parasitology Studies
338
Healthcare Policy
216
Zoonotic Infections
148
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,542
Articles tracked across the journal lifetime
Indexed publication set
319
236 cited publications
Last 12 months
116
9.7 publications/month
Open access share
22.4%
26 OA publications in the last year
Leading citing country
United States
348 citing publications
Leading citing field
Tropical Diseases
425 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v5n1, Mar. 1998-
v5n1, Mar. 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Tropical Diseases
Parasitology Studies
Virology
Zoonotic Infections
Parasitology
Issuing & Sponsoring Bodies
Contributor
International Society of Travel Medicine
Contributor
Asia Pacific Travel Health Association
Broad Categories
Communicable Diseases
Public Health
Tropical Diseases
Parasitology Studies
Virology
Parasitology
Zoonotic Infections
MeSH Descriptors
Communicable Disease Control
Preventive Medicine
Travel
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
DOI 10.1093/jtm/taag093
Open DOI
Prevalence of respiratory viruses among pilgrims in Saudi Arabia during the Hajj 2026: a cross-sectional study
Background: Hajj is one of the world's largest annual mass gatherings and provides favorable conditions for respiratory virus transmission because of intense crowding and extensive international travel. Contemporary post-pandemic molecul...
04
DOI 10.1093/jtm/taag092
Open DOI
Prolonged low-level inter-human mpox transmission in Nigeria prior to the global outbreak in 2022: a mathematical modelling study
Background: The 2022 global mpox outbreak was linked to clade IIb viruses that previously circulated in Nigeria. Genomic evidence suggests that, in Nigeria, sustained human-to-human transmission may have begun as early as 2016. Methods: ...
05
DOI 10.1093/jtm/taag088
Open DOI
Atovaquone-proguanil chemoprophylaxis during pregnancy: a case series and a systematic review and meta-analysis
Background: Pregnant women travelling to malaria endemic areas require effective chemoprophylaxis, with limited options including atovaquone-proguanil (AP) for which safety data remain limited. Our objective was to describe the prevalenc...
06
DOI 10.1093/jtm/taag087
Open DOI
Hypoxic pre-acclimatization strategies before rapid ascent for preventing acute mountain sickness: a systematic review and network meta-analysis
Background: Acute mountain sickness (AMS) commonly affects unacclimatized lowlanders travelling above 2500 m. Hypoxic pre-acclimatization may reduce AMS risk, but its effectiveness before rapid ascent and the relative merits of different...
07
DOI 10.1093/jtm/taag077
Open DOI
‘Africans Against Malaria’—introducing a new diaspora-led initiative to strengthen malaria prevention amongst UK-based travellers visiting friends and relatives in malaria-endemic African countries
Highlight: Use of malaria prevention methods, particularly chemoprophylaxis, amongst the UK-based African diaspora is low; a long-standing issue that remains inadequately addressed. Here, we present ‘Africans Against Malaria’, a unique i...
08
DOI 10.1093/jtm/taag086
Open DOI
Developing country vaccination recommendations for travellers: the UK National Travel Health Network and Centre methodology for typhoid and Hepatitis a
Background: The National Travel Health Network and Centre (NaTHNaC) regularly reviews country-specific vaccination recommendations to align with current epidemiological evidence. This update aimed to refine hepatitis A and typhoid vaccin...
09
DOI 10.1093/jtm/taag084
Open DOI
Management of travellers to high altitude with self-reported sulphonamide allergy: experience from a travel clinic in Thailand
Managing high-altitude travellers with self-reported sulphonamide allergy is challenging. History of severe allergies are managed conservatively, while those with non-severe allergies to antimicrobial sulphonamides may receive acetazolam...
10
DOI 10.1093/jtm/taag085
Open DOI
Early transmission risks of Ebola disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo
An outbreak of Ebola disease caused by Bundibugyo virus (BDBV) has been ongoing since April 2026, primarily in the Democratic Republic of the Congo. We estimated the initial reproduction number of BDBV at 1.85 (95% credible interval [CrI...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with vol. 22, no. 6 (Nov.-Dec. 2015).
Also issued online.
Official publication of the International Society of Travel Medicine and the Asia Pacific Travel Health Association, 1994-2005; of the International Society of Travel Medicine, 1994-